decisionhealth Newsletters, Coder Pink Sheets - 2013 Issue 7 (July)
Quick coding chart: Lidocaine – J2001
Subscribe or sign in to view the full article.
Article Overview
This article provides a compact reference for a lidocaine drug code, including a crosswalk table to product-level NDC information and discussion of denial patterns seen in audit review. It is intended for coders and billing staff who need to recognize the article’s scope around drug reporting, claim edits, and related denial categories.
Why This Topic Matters
The page is useful for teams reviewing drug reporting and denial management because it highlights a commonly audited billing issue and connects the drug code to product-level reference data. It can help users decide whether they need the full article for documentation, claim processing, or audit follow-up.
Article Sections
-
Codes
Introduces the drug code referenced in the chart and presents a plain-language reference format for the item covered by the article.
-
NCD Crosswalk – Lidocaine in D5w
Lists product-level NDC reference information associated with the article’s drug topic, including manufacturer and package details.
-
Coder’s notes
Summarizes audit-related context, denial categories, and the general claim-processing concerns associated with the drug topic.
What You Will Learn
- How the article frames lidocaine-related drug coding within a billing and audit context.
- What type of NDC crosswalk information is included for the drug topic.
- Which broad denial and payment-adjustment categories are discussed in relation to claim review.
- How the article situates the topic for coding and reimbursement review workflows.
Who Should Read This
- Medical coders
- Billing staff
- Compliance teams
- Revenue cycle professionals
- Audit reviewers
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com